“We imported some items from friendly countries, such as China and Russia. We've learned to do some of them ourselves. There was a fairly powerful impetus for the development of internal replacement for imported drug components,” said Yuri Pokhodnya, General Director of RUE Belpharmprom Holding Management Company.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
“We imported some items from friendly countries, such as China and Russia. We've learned to do some of them ourselves. There was a fairly powerful impetus for the development of internal replacement for imported drug components,” said Yuri Pokhodnya, General Director of RUE Belpharmprom Holding Management Company.